Anti thyroglobulin antibodies in the follow up of patients with differentiated thyroid cancer;Anticuerpos anti-tiroglobulina en el seguimiento de pacientes con cáncer diferenciado de tiroides: ¿Marcadores de enfermedad residual o recidivante?

Revista Medica de Chile

Volumn 130, Issue 2, 2002, Pages 167-172

  Quevedo L, Iván ^a   Campino J, Carmen ^a   Rodríguez Portales, José A ^a   Arteaga U, Eugenio ^a   López M, José Manuel ^a   Campusano M, Claudia ^a   González V, Gilberto ^a   Fardella B, Carlos ^a   Slater M, Jenny ^a   Valdivia V, Ligia ^a   Poggi M, Helena ^a   Foradori C, Arnaldo ^a   Velasco L, Soledad ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Antibodies, blocking; Thyroglobulin; Thyroid diseases

Indexed keywords

ANTI THYROGLOBULIN; ANTI-THYROGLOBULIN; AUTOANTIBODY; THYROGLOBULIN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; RETROSPECTIVE STUDY; THYROID TUMOR; THYROIDECTOMY; TUMOR RECURRENCE;

ADULT; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RETROSPECTIVE STUDIES; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036483421     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. VAN HERLE AJ, ULLER RP. Elevated serum thyroglobulin: A marker of metastases in differentiated thyroid carcinoma. J Clin Invest 1975; 56: 272-277.
2. OZATA M, SUSUKI S, MIYAMOTO T, TSUAN LIU R, FIERRO-RENOY F, DE GROOT LJ. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994; 79: 98-105.
3. BLACK EG, SHEPPARD MC, HOFFENBERG R. Serial thyroglobulin measurements in the management of differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 1987; 27:115-120.
4. CAMPINO C, ARTEAGA E, VALDIVIA L, FORADORI A, LÓPEZ JM, POGGI H. Autoanticuerpos anti-tiroglobulina: detección y posible interferencia en la medición de tiroglobulina en suero. Rev Méd Chile 1999; 127: 667-674.
5. SPENCER CA, TAKEUCHI M, KAZAROSYAN M, WANG CC, GUTTLER RB, SINGER PA, ET AL. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 1121-1127.
6. MARIOTTI S, BARBESINO G, CATUREGLI P, MARINÓ M, MANETTI L, PACINI F ET AL. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: An unobtainable goal? J Clin Endocrinol Metab 1995; 80: 468-472.
7. RUBELLO D, CASARA D, GIRELLI ME, PICCOLO M, BUSNARDO B. Clinical meaning of circulating anti-thyroglobulin antibodies in differentiated thyroid cancer: a prospective study. J Nucl Med 1992; 33: 1478-1480.
8. TUMINO S, BELFIORE A. Appearance of antithyroglobulin antibodies as the sole sign of metastatic lymph nodes in a patient operated on for papillary thyroid cancer: A case report. Thyroid 2000; 10: 431-433.
9. ANDRZEJEWSKI C JR. Lymphocytes in the thyroid. En Surgical pathology of the thyroid. Editor Livolsi, 1990 pag. 68-97.
10. LITTELL R, MILLIKEN G, STROUP W, WOLFINGER R. S.A.S. System for mixed models. S.A.S. Institute Inc, Cary, NC, USA 1996 pag. 87-134.
11. PACINI F, MARIOTTI S, FORMICA N, ELISEI R, ANELLI S, CAPOTORTI E, ET AL. Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome. Acta Endocrinol (Copenh) 1988; 119; 373-380.
12. HJIYIANNAKIS P, MUNDY J, HARMER C. Thyroglobulin antibodies in differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 1999; 11: 240-244.